62Z-12052-50008
4 vaccinations
4 coded responses
52 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 787 / TX
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Registered in v-safe
-
2021-02-08
Dose 1 — Moderna
- 2021-02-08
-
2021-02-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-02-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
-
2021-03-10
Dose 2 — Moderna
- 2021-03-10
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Heart rate increased — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: My heart rate increased by about 20-30 beats/minute, through the night, but it has since normalizedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-04-21
- 2021-06-09
- 2021-09-08
-
2021-12-07
Dose 3 — Moderna
-
2021-12-10
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea — Feeling: Good · Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
-
2022-04-18
Dose 4 — Moderna
-
2022-04-19
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-20
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2022-04-21
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2022-04-22
- 2022-04-23
- 2022-04-24
- 2022-04-25
- 2022-05-02
- 2022-05-09
- 2022-05-16
- 2022-05-23
- 2022-05-30
- 2022-07-18
- 2022-10-17
-
2023-04-18
Survey response — 12 months, dose 4MedDRA: COVID-19, Diarrhoea, Fatigue, Nasal congestion, Oropharyngeal pain, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-04-18
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-04-19
-
2023-04-19
Callback requested for11:45AM ET
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Moderna | |
| 2 | 2021-03-10 | Moderna | |
| 3 | 2021-12-07 | Moderna | No |
| 4 | 2022-04-18 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-04-18 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): My heart rate increased by about 20-30 beats/minute, through the night, but it has since normalized
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Shortness of breath
Systemic reaction (other): Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release